Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis

Summary

The purpose of this research study is to see how well patients in an early phase of their illness respond to treatment and whether this depends on how well they functioned socially, academically and vocationally before becoming ill. The study also examines whether patients with more insight into their illness have better outcomes.

Timeline

Start

2006-03

Primary completion

—

Completion

2007-11

Drugs

Indications